Pavmed Inc. · NASDAQ:PAVM
Ayrton Capital LLC reported a 9.99% stake in Pavmed Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 11, 2026
Ayrton Capital LLC reported a 9.99% stake in Pavmed Inc., 709,069 shares, as a passive investor on Mar 31, 2026. Filed May 11, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 709,069
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ayrton Capital LLC | 9.99% | 709,069 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 9.99% | 709,069 |
| Waqas Khatri | 9.99% | 709,069 |
Source
Related
- Pavmed Inc.
- Ayrton Capital LLC
- Pavmed Inc. shareholders
- Schedule 13G/A · Ayrton Capital LLC · Feb 13, 2025
- Schedule 13G/A · Nagelberg David S · Aug 13, 2026
- Schedule 13G · Two Seas Capital LP · May 15, 2026
- Schedule 13G · First Manhattan Co. LLC. · May 14, 2026
- Schedule 13G/A · Dana Carrera · Apr 14, 2026
- Form 4 · Lee Victoria Tou-ho · Apr 13, 2026